Document:

Non-Statutory Stock Option Agreement

 Exhibit 10.29 
 CAMBRIDGE HEART, INC. 
 Stock Option Agreement 
 Granted Outside 2001 Stock Incentive Plan 
 1. Grant of Option. 
 This agreement evidences the grant by Cambridge Heart, Inc., a Delaware corporation (the “Company”), on December 11, 2007 (the “Grant Date”) to
Ali Haghighi-Mood, an employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein, a total of 450,000 shares (the “Shares”) of common stock, $.001 par value per share,
of the Company (“Common Stock”) at $1.15 per Share (the “Option”). Unless earlier terminated, this Option shall expire on December 11, 2017 (the “Final Exercise Date”). 
 This Option is granted outside of the Company’s equity incentive plans as a stand-alone award. The Option shall nevertheless be subject to the terms of the
Company’s 2001 Stock Incentive Plan (the “Plan”), as amended from time to time, as if it had been granted thereunder. A copy of the Plan is attached hereto and is incorporated herein in its entirety by reference. 
 It is intended that the option evidenced by this agreement shall not be an incentive stock option as defined in Section 422 of the Internal Revenue Code of 1986, as
amended, and any regulations promulgated thereunder (the “Code”). Except as otherwise indicated by the context, the term “Participant”, as used in this option, shall be deemed to include any person who acquires the right to
exercise this option validly under its terms. 
 2. Vesting Schedule. 
 (a) General. This Option will become exercisable (“vest”) as to 33.3% of the original number of Shares on the first anniversary of the Grant Date and as to an additional 33.3% of the original number
of Shares at the end of each successive one-year period following the first anniversary of the Grant Date until the third anniversary of the Grant Date. 
 (b) Cumulative Right of Exercise. The right to exercise the Option shall be cumulative so that to the extent the Option is not exercised in any period to the maximum extent permissible it shall continue to be
exercisable, in whole or in part, with respect to all shares for which it is vested until the earlier of the Final Exercise Date or the termination of this Option under Section 3 hereof or the Plan. 
 3. Exercise of Option. 
 (a) Form of Exercise.
Each election to exercise this Option shall be in writing, signed by the Participant, and received by the Company at its principal office, accompanied by this agreement, and payment in full in the manner provided in the Plan. The Participant may
purchase less than the number of shares covered hereby, provided that no partial exercise of this Option may be for any fractional share. 
  

 (b) Continuous Relationship with the Company Required. Except as otherwise provided in this
Section 3, this Option may not be exercised unless the Participant, at the time he or she exercises this Option, is, and has been at all times since the Grant Date, an employee, officer or director of, or consultant or advisor to, the Company
or any parent or subsidiary of the Company as defined in Section 424(e) or (f) of the Code (an “Eligible Participant”). 
 (c) Termination of Relationship with the Company. If the Participant ceases to be an Eligible Participant for any reason, then, except as provided in paragraphs (d) and (e) below, the right to exercise this Option shall
terminate three months after such cessation (but in no event after the Final Exercise Date), provided that this Option shall be exercisable only to the extent that the Participant was entitled to exercise this Option on the date of such
cessation. Notwithstanding the foregoing, if the Participant, prior to the Final Exercise Date, violates the non-competition or confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement
between the Participant and the Company, the right to exercise this Option shall terminate immediately upon such violation. 
 (d)
Exercise Period Upon Death or Disability. If the Participant dies or becomes disabled (within the meaning of Section 22(e)(3) of the Code) prior to the Final Exercise Date while he or she is an Eligible Participant and the Company has
not terminated such relationship for “cause” as specified in paragraph (e) below, this Option shall be exercisable, within the period of one year following the date of death or disability of the Participant, by the Participant (or in
the case of death by an authorized transferee), provided that this Option shall be exercisable only to the extent that this Option was exercisable by the Participant on the date of his or her death or disability, and further provided that
this Option shall not be exercisable after the Final Exercise Date. 
 (e) Discharge for Cause. If the Participant, prior to the Final
Exercise Date, is discharged by the Company for “Cause” (as defined below), the right to exercise this Option shall terminate immediately upon the effective date of such discharge. “Cause” shall mean willful misconduct by the
Participant or willful failure by the Participant to perform his or her responsibilities to the Company (including, without limitation, breach by the Participant of any provision of any employment, consulting, advisory, nondisclosure,
non-competition or other similar agreement between the Participant and the Company), as determined by the Company, which determination shall be conclusive. The Participant shall be considered to have been discharged for “Cause” if the
Company determines, within 30 days after the Participant’s resignation, that discharge for cause was warranted. 
 4. Withholding. 
 No Shares will be issued pursuant to the exercise of this Option unless and until the Participant pays to the Company, or makes provision satisfactory to the Company for
payment of, any federal, state or local withholding taxes required by law to be withheld in respect of this Option. 
 5. Nontransferability of
Option. 
 This Option may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of
law, except by will or the laws of descent and distribution, and, during the lifetime of the Participant, this Option shall be exercisable only by the Participant. 
  

 2 

 6. Provisions of the Plan. 
 This Option is subject to the provisions of the Plan, a copy of which is furnished to the Participant with this Option. 
 IN WITNESS WHEREOF, the
Company has caused this Option to be executed under its corporate seal by its duly authorized officer. This Option shall take effect as a sealed instrument. 
 CAMBRIDGE HEART, INC. 
 Dated:
December 11, 2007 
 By:  /s/    Vincenzo
LiCausi                              
         Name: Vincenzo LiCausi 
         Title: Chief Financial Officer 
  

 3 

 PARTICIPANT’S ACCEPTANCE 
 The undersigned hereby accepts the foregoing Option and agrees to the terms and conditions thereof. The undersigned hereby acknowledges receipt of a copy of the Company’s 2001 Stock Incentive Plan. 
 PARTICIPANT: 
 /s/    Ali
Haghighi-Mood                                     
 Address:  ___________________________ 
                  ___________________________

                  ___________________________ 
  

 4 

 NOTICE OF STOCK OPTION EXERCISE 
 Date:
                                        
         
 Cambridge Heart, Inc. 
 1 Oak Park Drive 
 Bedford, MA 01730 
 Attention: Treasurer 
 Dear Sir or Madam: 
 I am the
holder of a Nonstatutory Stock Option granted to me outside of the Company’s equity incentive plans but nevertheless subject to the terms of the Cambridge Heart, Inc. (the “Company”) 2001 Stock Incentive Plan on December 11, 2007
for the purchase of 450,000 shares of Common Stock of the Company at a purchase price of $1.15 per share. 
 I hereby exercise my Option to purchase
                 shares of Common Stock (the “Shares”), for which I have enclosed
                 in the amount of                 . Please register my stock certificate
as follows: 
  

					
			
	 Name(s):
	  	 	  	
			
		  	 	  	
			
	 Address:
	  	 	  	
			
		  	 	  	
			
		  	 	  	
			
	 Tax I.D. #:
	  	 	  	

 Very truly yours, 
 _______________________________________ 
 (Signature) 
  

 5Form of Memorandum to Board of Directors dated October 1,2007

 Exhibit 10.43 
 [Cambridge Heart logo] 
 October 1, 2007 
         TO:  Board of Directors of Cambridge Heart 
  FROM:  Robert
P. Khederian, Chairman of the Board and Interim CEO 
         RE:  Amendment to Non-Employee
Director Stock Options 
  
  
 This letter will serve as notice that pursuant to resolutions duly adopted by the Board of Directors of Cambridge Heart, Inc. (the “Company”)
on October 1, 2007 (the “Approval Date”), all outstanding stock options granted as of the Approval Date under the Company’s 2001 Stock Incentive Plan to non-employee directors of the Company for service as a director to the Company
have been amended to provide that all such stock options will immediately become exercisable in full in the event that a Change in Control (as defined below) of the Company occurs (except with respect to any portion of stock options that have been
exercised, forfeited or terminated prior to the date of the Change in Control). All such stock options (including the portion accelerated upon a Change of Control) must be exercised within the time periods set forth in your option agreement(s) and
the 2001 Stock Incentive Plan. 
 For the sake of greater certainty, please note that the stock options covered by the foregoing amendment
are set forth on the attached Schedule A and that all other outstanding stock option held by non-employee directors as of the Approval Date remain unchanged and are not affected by the foregoing amendment. 
 The term “Change in Control” means an event or occurrence set forth in any one or more of subsections (a) through (c) below (including
an event or occurrence that constitutes a Change in Control under one of such subsections but is specifically exempted from another such subsection): 
 (a) The acquisition by an individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) (a “Person”) of
beneficial ownership of any capital stock of the Company if, after such acquisition, such Person beneficially owns (within the meaning of Rule 13d-3 promulgated under the Exchange Act) 50% or more of either (i) the then-outstanding shares of common
stock of the Company (the “Outstanding Company Common Stock”) or (ii) the combined voting power of the then-outstanding securities of the Company entitled to vote generally in the election of directors (the “Outstanding Company Voting
Securities”); provided, however, that for purposes of this subsection (a), the following acquisitions shall not constitute a Change in Control: (i) any acquisition directly from the Company, (ii) any acquisition by the
Company or (iii) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any corporation controlled by the Company; or 

 (b) Such time as the Continuing Directors (as defined below) do not constitute a majority of the Board
(or, if applicable, the Board of Directors of a successor corporation to the Company), where the term “Continuing Director” means at any date a member of the Board (i) who was a member of the Board on the date of the execution of this
Agreement or (ii) who was nominated or elected subsequent to such date by at least a majority of the directors who were Continuing Directors at the time of such nomination or election or whose election to the Board was recommended or endorsed by at
least a majority of the directors who were Continuing Directors at the time of such nomination or election; or 
 (c) The consummation of a
merger, consolidation, reorganization, recapitalization or statutory share exchange involving the Company or a sale or other disposition of all or substantially all of the assets of the Company (a “Business Combination”), unless,
immediately following such Business Combination, all or substantially all of the individuals and entities who were the beneficial owners of the Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior to such
Business Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of common stock and the combined voting power of the then-outstanding securities entitled to vote generally in the election of directors,
respectively, of the resulting or acquiring corporation in such Business Combination in substantially the same proportions as their ownership, immediately prior to such Business Combination, of the Outstanding Company Common Stock and Outstanding
Company voting Securities, respectively. 
 /s/    Robert P.
Khederian                                     
 Robert P. Khederian 
 Chairman, Interim President and CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00139-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00139-of-00352.parquet"}]]